Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Exxon Mobil
XOM
|
+$151M |
| 2 |
GE Vernova
GEV
|
+$139M |
| 3 |
Ferrovial SE
FER
|
+$60.1M |
| 4 |
Strategy Inc Common Stock Class A
MSTR
|
+$24M |
| 5 |
Solventum
SOLV
|
+$22.9M |
Top Sells
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$184M |
| 2 |
GE Aerospace
GE
|
+$135M |
| 3 |
Apple
AAPL
|
+$117M |
| 4 |
Microsoft
MSFT
|
+$110M |
| 5 |
Meta Platforms (Facebook)
META
|
+$80.5M |
Sector Composition
| 1 | Technology | 33.84% |
| 2 | Healthcare | 12.16% |
| 3 | Consumer Discretionary | 11.34% |
| 4 | Communication Services | 9.35% |
| 5 | Industrials | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1801
Xencor
XNCR
$596M
| $2.03M | ﹤0.01% |
107,500
| – | – |
|
1802
Herbalife
HLF
$958M
| $2.03M | ﹤0.01% |
195,072
| – | – |
|
|
CIM
1803
Chimera Investment
CIM
$1.17B
| $2.03M | ﹤0.01% |
158,327
+9,400
| +6% | +$120K |
|
1804
ACM Research
ACMR
$1.93B
| $2.02M | ﹤0.01% |
87,800
| – | – |
|
1805
LegalZoom.com
LZ
$1.84B
| $2.02M | ﹤0.01% |
241,200
| – | – |
|
|
PDS
1806
Precision Drilling
PDS
$759M
| $2.02M | ﹤0.01% |
28,800
+200
| +0.7% | +$14.1K |
|
|
HIBB
1807
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $2.02M | ﹤0.01% |
23,200
| – | – |
|
|
EFC
1808
Ellington Financial
EFC
$1.36B
| $2.02M | ﹤0.01% |
167,400
+15,700
| +10% | +$190K |
|
1809
Kimbell Royalty Partners
KRP
$1.29B
| $2.02M | ﹤0.01% |
123,500
-7,500
| -6% | -$123K |
|
1810
SoundHound AI
SOUN
$5.94B
| $2.02M | ﹤0.01% |
510,500
+117,600
| +30% | +$465K |
|
1811
National Vision
EYE
$1.79B
| $2.02M | ﹤0.01% |
154,000
| – | – |
|
1812
Cannae Holdings
CNNE
$1.1B
| $2.02M | ﹤0.01% |
111,094
-21,500
| -16% | -$390K |
|
|
NWLI
1813
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $2.01M | ﹤0.01% |
4,049
| – | – |
|
|
MORF
1814
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $2.01M | ﹤0.01% |
58,900
| – | – |
|
1815
Kura Oncology
KURA
$766M
| $2M | ﹤0.01% |
97,300
-5,100
| -5% | -$105K |
|
|
CSR
1816
Centerspace
CSR
$972M
| $2M | ﹤0.01% |
29,500
| – | – |
|
1817
Peoples Bancorp
PEBO
$1.09B
| $1.99M | ﹤0.01% |
66,300
| – | – |
|
1818
Alphatec Holdings
ATEC
$2.27B
| $1.99M | ﹤0.01% |
190,000
+1,700
| +0.9% | +$17.8K |
|
1819
TeraWulf
WULF
$4.34B
| $1.98M | ﹤0.01% |
+445,800
| New | +$1.98M |
|
|
SA
1820
Seabridge Gold
SA
$1.8B
| $1.98M | ﹤0.01% |
145,200
+4,500
| +3% | +$61.5K |
|
|
SILK
1821
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $1.98M | ﹤0.01% |
+73,300
| New | +$1.98M |
|
1822
Bumble
BMBL
$702M
| $1.98M | ﹤0.01% |
188,300
| – | – |
|
1823
QCR Holdings
QCRH
$1.32B
| $1.98M | ﹤0.01% |
32,939
| – | – |
|
1824
Jack in the Box
JACK
$342M
| $1.96M | ﹤0.01% |
38,500
-500
| -1% | -$25.5K |
|
|
BBT
1825
Beacon Financial Corporation
BBT
$2.2B
| $1.96M | ﹤0.01% |
85,800
-1,000
| -1% | -$22.8K |
|